GL1X · GenesisL1 explorer

MolNFT v1 · #190222 · protein

Discovery of SARS-cov-2 3CLPRO peptidomimetic inhibitors through H41- specific protein-ligand interactions

7WO1 · 3C-like proteinase: “Discovery of SARS-cov-2 3CLPRO peptidomimetic inhibitors through H41- specific protein-ligand interactions”. X-ray diffraction, 1 ligand (3XI), 3 pockets (best druggability 0.54). MolNFT v1 #190222 on GenesisL1…

PDB
7WO1
Type
protein
Length
306 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTC1
Ligands
3XI
Pockets
3 · best druggability 0.54

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30626% helix, 28% strandP0DTC1

Ligands and binding sites

  • 3XI · N-[(2S)-3-methyl-1-[[(2S)-4-methyl-1-oxidanylidene-1-[[(2S)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepiperidin-3-yl]propan-2-yl]amino]pentan-2-yl]amino]-1-oxidanylidene-butan-2-yl]cyclohexanecarboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12120.540.78283XI
2630.500.8513empty
3690.300.7316empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7WO1 · Discovery of SARS-CoV-2 3CLpro peptidomimetic inhibitors through H41-specific… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.